Review Article

The Importance of Assessing Nutritional Status to Ensure Optimal Recovery during the Chronic Phase of Stroke

Table 1

Nutritional considerations for the prevention of metabolic, physical, and psychological dysfunction in adult chronic stroke survivors.

Nutritional considerationDietary Reference Intake (United States and Canada) [25, 26]/Dietary Guidelines for Americans (United States) [27]UL (United States and Canada) [25, 26]Indicator of nutritional riskPotential role in the prevention of metabolic, physical, and psychological dysfunction

Energy and macronutrient balance

EnergyDietary guidelines
Males: 2,000–3,000 kcals/d, depending upon age and activity level 
Females: 1,600–2,400 kcals/d, depending upon age and activity level
NDSerum albumin
Reference range: 3.5–5.0 g/dL
Increased risk: <3.2 g/dL  
Serum prealbumin  
Reference range: 15–35 mg/dL
Increased risk: <15 mg/dL
(i) Sarcopenic obesity prevention
​  (a) Maintenance of muscle mass 
​  (b) Prevention of excessive adipose tissue accumulation
(i) CarbohydratesRDA (AMDR)
Both sexes: 130 g/d (45–65%)
ND, but <10% of daily calories should come from added sugars
(ii) ProteinRDA (AMDR)
Both sexes: 0.8 g/kg/d (10–35%)
ND
(iii) FatAMDR
Both sexes: 20–35%
ND, but <10% of daily calories should come from saturated fat

Other nutrients

B-vitamins

(i) FolateRDA
Both sexes: 400 μg/d
1000 μg/dSerum folate
Reference range: 6–20 ng/ml
Deficiency: <3 ng/ml 
Red blood cell folate:
Reference range: 140–628 ng/mL
Deficiency: <100 ng/ml
(ii) Vitamin B6RDA
Both sexes: 19–50 y: 1.3 mg/d 
Males: 51+ y: 1.7 mg/d 
Females: 51+ y: 1.5 mg/d 
100 mg/dPlasma pyridoxal 5-phosphate
Reference range: 11–302 nmol/L
Deficiency: <10 nmol/L
(i) Physical dysfunction prevention
(ii) Depressive symptom prevention
(iii) Cognitive impairment prevention
  (a) Reduced homocysteine
(iii) Vitamin B12RDA
Both sexes: 2.4 μg/
NDSerum B12
Reference range: 500–900 pg/mL
Deficiency: <200 pg/mL
Vitamin DRDA
Both sexes:
19–70 y: 15 μg/d
70+ y: 20 μg/d
100 μg/dSerum 25(OH)D
Reference range: 30–100 ng/mL
Insufficiency: 20–30 ng/mL
Deficiency: <20 ng/mL
(i) Fracture prevention
(ii) Depressive symptom prevention
Vitamin KAI
Males: 120 μg/d
Females: 90 μg/d
NDPlasma phylloquinone
Reference range: 0.25–2.67 nmol/L
Insufficiency/Deficiency: ND (<0.2 nmol/L considered “low”)
(i) Fracture prevention
Omega 3AI (α-linolenic acid)
Males: 1.6 g/d 
Females: 1.1 g/d
NDOmega 3 index ([sum of 3 omega 3 fatty acids ÷ total phospholipid fatty acids] × 100)
Reference range: 1.4–4.9%
Increased Risk: <3.2% 
Omega 6/omega 3 (sum of 6 omega 6 fatty acids ÷ sum of 3 omega 3 fatty acids)
Reference range: 5.7–21.3
Increased risk: >5
(i) Physical dysfunction prevention
  (a) Maintenance of muscle mass 
  (b) Reduced inflammation and oxidative stress 
(ii) Depressive symptom prevention
(iii) Cognitive impairment prevention

RDA = Recommended Dietary Allowance, AI = Adequate Intake, UL = Tolerable Upper Intake Level, AMDR = Acceptable Macronutrient Distribution Range, and ND = not determinable. older people may malabsorb food-bound B12, it is advisable to meet RDA through foods fortified with vitamin B12 or supplements containing B12.